Fundz

Eupraxia Pharmaceuticals reported raising $128,000 in an initial SEC Form D filing, from an offering of $128,000

PUBLIC · EPRXAug 22, 2023

Amount Raised

$128,000

$128,000 sold, per SEC Form D (first sale Aug 18, 2023)

Round Type

Pre-Seed

VictoriaBiotechnology

Quick answer

Eupraxia Pharmaceuticals raised $128,000 in a Pre-Seed round, dated August 18, 2023. Eupraxia Pharmaceuticals is based in Victoria, British Columbia, Canada.

How much did Eupraxia Pharmaceuticals raise?
Eupraxia Pharmaceuticals raised $128,000 in a Pre-Seed round on August 18, 2023.
What does Eupraxia Pharmaceuticals do?
Eupraxia is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to currently approved drugs.
Where is Eupraxia Pharmaceuticals based and how big is it?
Eupraxia Pharmaceuticals is based in Victoria, British Columbia, Canada.
Who are the decision-makers at Eupraxia Pharmaceuticals?
Fundz holds 1 contact at Eupraxia Pharmaceuticals. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Eupraxia Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.

  • Mogrify raised an undisclosed amount (Series A) on October 2, 2023.
  • PanTheryx, Inc. raised $52M on October 2, 2023.
  • Flat Medical raised an undisclosed amount (Series C) on October 2, 2023.
  • Piccolo Medical raised $5.5M (Series B) on October 2, 2023.
  • Amicus Therapeutics raised an undisclosed amount (Funding Round) on October 2, 2023.
  • SAB Biotherapeutics raised $7.5M on October 2, 2023.

Who to call at Eupraxia Pharmaceuticals, and when

A new round usually means Eupraxia Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Eupraxia Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Eupraxia Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Eupraxia Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Eupraxia Pharmaceuticals

Location

201-2067 CADBORO BAY RD.

Victoria, British Columbia, Canada

About

Eupraxia is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to currently approved drugs. Each of Eupraxia's product candidates has the potential to address therapeutic areas with high unmet medical need, and strives to provide improved patient benefit by delivering targeted, long-lasting activity with fewer side effects. In addition to Eupraxia’s lead product candidate, EP-104IAR, Eupraxia is developing a pipeline of earlier-stage long-acting formulations. Potential pipeline candidates include a range of drugs for indications such as post-surgical pain (EP-105), and post-surgical site infections (EP-201), each designed to improve on the activity and tolerability of approved drugs. Eupraxia is also developing a formulation of EP-104IAR for use in canine and equine osteoarthritis.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Eupraxia Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts6 people are listed at Eupraxia Pharmaceuticals. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Eupraxia Pharmaceuticals's next move

See what Strategic adds

Eupraxia Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.